Astrana Health (ASTH) Receivables - Net (2011 - 2026)

Astrana Health has reported Receivables - Net for 16 years, with the latest figure at $467.4 million in Q1 2026.

• Quarterly Receivables - Net rose 751.78% year-over-year to $467.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $467.4 million (up 751.78% YoY) and the FY2025 annual result came in at $374.5 million, up 35.68% from the prior year.
• Receivables - Net rose to $467.4 million in Q1 2026 per ASTH's latest filing, from $374.5 million in the prior quarter.
• Over five years, Receivables - Net peaked at $467.4 million in Q1 2026 and troughed at $1.0 million in Q1 2022.
• A 5-year average of $150.3 million and a median of $76.0 million in 2023 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net plunged 93.88% in 2022, then jumped 7447.67% in 2023.
• Over 5 years, Receivables - Net stood at $62.4 million in 2022, then fell by 5.95% to $58.7 million in 2023, then jumped by 370.11% to $276.0 million in 2024, then jumped by 35.68% to $374.5 million in 2025, then climbed by 24.82% to $467.4 million in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $467.4 million, $374.5 million, and $381.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.